Goldman Sachs Group Inc Kamada LTD Transaction History

Goldman Sachs Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$4.86 - $5.83 $52,842 - $63,389	10,873 New	10,873 $58,000
Q3 2023 Nov 14, 2023	SELL	$4.86 - $5.83 $6,347 - $7,613	-1,306 Reduced 10.72%	10,873 $58,000
Q2 2023 May 14, 2024	SELL	$4.48 - $5.53 $26,387 - $32,571	-5,890 Reduced 32.6%	12,179 $64,000
Q2 2023 Aug 14, 2023	SELL	$4.48 - $5.53 $26,387 - $32,571	-5,890 Reduced 32.6%	12,179 $64,000
Q1 2023 May 14, 2024	SELL	$4.12 - $5.25 $51,524 - $65,656	-12,506 Reduced 40.9%	18,069 $83,000
Q1 2023 May 11, 2023	SELL	$4.12 - $5.25 $51,524 - $65,656	-12,506 Reduced 40.9%	18,069 $83,000
Q4 2022 May 14, 2024	SELL	$3.79 - $4.84 $40,147 - $51,270	-10,593 Reduced 25.73%	30,575 $122,000
Q4 2022 Feb 13, 2023	SELL	$3.79 - $4.84 $40,147 - $51,270	-10,593 Reduced 25.73%	30,575 $122,000
Q3 2022 May 14, 2024	BUY	$4.42 - $5.43 $38,069 - $46,768	8,613 Added 26.46%	41,168 $185,000
Q3 2022 Nov 10, 2022	BUY	$4.42 - $5.43 $38,069 - $46,768	8,613 Added 26.46%	41,168 $0
Q2 2022 May 14, 2024	BUY	$4.22 - $5.85 $137,382 - $190,446	32,555 New	32,555 $146,000
Q2 2022 Aug 15, 2022	SELL	$4.22 - $5.85 $20,943 - $29,033	-4,963 Reduced 13.23%	32,555 $146,000
Q1 2022 May 16, 2022	BUY	$5.43 - $6.81 $122,587 - $153,742	22,576 Added 151.09%	37,518 $208,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $180,380 - $236,122	-34,622 Reduced 69.85%	14,942 $98,000
Q3 2021 Nov 10, 2021	BUY	$5.25 - $5.87 $260,211 - $290,940	49,564 New	49,564 $263,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.